Dr. Fred Locke

Join Dr. Fred Locke, a pioneer in CAR T-cell therapy and Chair at Moffitt Cancer Center, as he shares his journey inspired by his father's battle with lymphoma. He discusses groundbreaking clinical trials ZUMA-1 and ZUMA-7, revealing how CAR T treatments are revolutionizing lymphoma care. Dr. Locke dives into the science behind CAR T technology, survival strategies against solid tumors, and innovative approaches like donor-derived therapies. Plus, learn how diet and exercise may enhance therapy outcomes, paving the way for outpatient care.